JZJ(SH:605266)2023-04-26 16:00Financial Performance - The company's revenue for Q1 2023 reached ¥2,166,874,356.81, representing a 49.41% increase compared to ¥1,450,283,191.81 in the same period last year[5]. - Net profit attributable to shareholders was ¥76,303,944.55, a significant increase of 143.67% from ¥29,365,396.05 in the previous year[5]. - The net profit for Q1 2023 reached 75,474,057.39, an increase of 148.95% compared to 30,317,243.58 in the same period last year[19]. - The basic earnings per share rose to ¥0.77, up 67.39% from ¥0.43 in the same quarter last year[6]. - Operating profit for Q1 2023 was ¥99,383,033.13, up 134.5% from ¥42,443,003.86 in Q1 2022[64]. - The company reported a total comprehensive income of ¥75,474,057.39 for Q1 2023, compared to ¥30,317,243.58 in Q1 2022[65]. - The company reported a net profit attributable to shareholders increased by 143.67% year-on-year[38]. Revenue Growth - Revenue from sales of goods and services was 2,331,854,747.76, representing an 82.39% increase from 1,278,501,199.83 in Q1 2022[19]. - Online channel revenue increased by 62.65% year-on-year, contributing to the overall growth of the multi-channel sales model[40]. - Prescription drug sales revenue grew by 72.88% year-on-year, increasing its share from 31.19% to 36.20%[41]. - The sales revenue of non-prescription drugs increased by 52.22% year-on-year, with its share rising from 37.12% to 37.94%[41]. - The total online revenue for the first quarter of 2023 reached 479.70 million yuan, a 62.65% increase compared to the same period last year[48]. Store Expansion - The number of stores increased by 1,058, resulting in a store growth rate of 33.76% compared to the same period last year[8]. - The total number of stores reached 4,192 in Q1 2023, with a net increase of 137 stores, representing a growth rate of 3.38%[25]. - The company opened 105 new stores and acquired 34 stores during the quarter, while closing 2 stores[26]. - The company is focusing on expanding its store network in key regions such as the Yangtze River Economic Belt and the Guangdong-Hong Kong-Macao Greater Bay Area[24]. - The company is implementing a dual strategy of self-built and acquired stores to penetrate core cities and strengthen its market position in profit centers like Yunnan and Hebei[24]. Cash Flow and Assets - The net cash flow from operating activities was ¥332,485,173.59, a recovery from a negative cash flow of ¥27,843,634.14 in the previous year[6]. - Cash received from operating activities related to other income surged to 48,971,580.78, a dramatic increase of 3,764.55% from 1,267,201.21[19]. - The company's total assets at the end of Q1 2023 were ¥9,460,634,810.71, a slight decrease of 1.91% from ¥9,385,265,346.27 at the end of the previous year[6]. - The company's current assets totaled CNY 3,784,861,062.01, down from CNY 3,939,388,508.01, indicating a decrease of about 3.9%[60]. - The company's cash and cash equivalents decreased to CNY 803,605,541.18 from CNY 932,600,793.46, representing a decline of approximately 13.8%[59]. Cost and Expenses - Operating costs rose to ¥1,460,181,587.44, reflecting a 51.39% increase from ¥964,525,413.43 in the previous year[18]. - Sales expenses increased by 35.98% to ¥532,538,365.18, driven by higher employee compensation, rental fees, and third-party service costs[18]. - Financial expenses rose by 63.65% to ¥32,683,521.27, primarily due to increased interest expenses from short-term and long-term borrowings[18]. - Cash paid for employee compensation increased by 94.13% to 418,381,640.53 from 215,516,673.36, reflecting a rise in workforce and salaries[19]. - Cash paid for various taxes increased by 326.51% to 88,045,895.51 from 20,643,230.49, indicating higher tax obligations due to increased revenue[19]. Strategic Focus - The company is focusing on strategic expansion and enhancing cooperation with prescription drug and OTC brand manufacturers to drive growth[8]. - The company plans to continue expanding its market presence and enhancing service offerings through new store openings and improved supplier relationships[18]. - The company aims to enhance its operational efficiency and brand recognition in county-level and above markets, with 95.36% of stores located in these areas[27]. - The company is committed to a community-oriented service model, positioning itself as a "family doctor, health advisor, and good neighbor" in the community[28]. - The company is focused on building a talent pipeline and management structure to support its expansion strategy[24].